e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
C. Daley, J. Iaccarino, C. Lange et al.
Source:
Guideline 2020
Number:
2020
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Daley, J. Iaccarino, C. Lange et al.. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Guideline 2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018
Year: 2018
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Source: Virtual Congress 2020 – German programme 2020
Year: 2020
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016
Year: 2017
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease
Source: Eur Respir Monogr 2018; 81: 204-221
Year: 2018
New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Year: 2020
Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018
Year: 2019
Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Year: 2017
Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Source: Eur Respir J 2016; 47: 45-68
Year: 2016
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Source: Guideline 2016
Year: 2016
An expert statment on clinical considerations before treating NTM lung infection
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis
Source: Eur Respir J 2016; 48: 963-971
Year: 2016
Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept